1. Home
  2. NSPR vs ZJYL Comparison

NSPR vs ZJYL Comparison

Compare NSPR & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • ZJYL
  • Stock Information
  • Founded
  • NSPR 2005
  • ZJYL 2006
  • Country
  • NSPR United States
  • ZJYL China
  • Employees
  • NSPR N/A
  • ZJYL N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • ZJYL Industrial Specialties
  • Sector
  • NSPR Health Care
  • ZJYL Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • ZJYL Nasdaq
  • Market Cap
  • NSPR 99.7M
  • ZJYL 111.3M
  • IPO Year
  • NSPR N/A
  • ZJYL 2023
  • Fundamental
  • Price
  • NSPR $1.81
  • ZJYL $0.27
  • Analyst Decision
  • NSPR Strong Buy
  • ZJYL
  • Analyst Count
  • NSPR 2
  • ZJYL 0
  • Target Price
  • NSPR $4.50
  • ZJYL N/A
  • AVG Volume (30 Days)
  • NSPR 119.5K
  • ZJYL 2.9M
  • Earning Date
  • NSPR 11-04-2025
  • ZJYL 08-20-2025
  • Dividend Yield
  • NSPR N/A
  • ZJYL N/A
  • EPS Growth
  • NSPR N/A
  • ZJYL N/A
  • EPS
  • NSPR N/A
  • ZJYL 0.01
  • Revenue
  • NSPR $7,779,000.00
  • ZJYL $22,826,624.00
  • Revenue This Year
  • NSPR $7.48
  • ZJYL N/A
  • Revenue Next Year
  • NSPR $104.39
  • ZJYL N/A
  • P/E Ratio
  • NSPR N/A
  • ZJYL $23.51
  • Revenue Growth
  • NSPR 14.04
  • ZJYL 13.42
  • 52 Week Low
  • NSPR $1.77
  • ZJYL $0.22
  • 52 Week High
  • NSPR $3.80
  • ZJYL $2.17
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 22.72
  • ZJYL 31.80
  • Support Level
  • NSPR $2.05
  • ZJYL $0.23
  • Resistance Level
  • NSPR $2.40
  • ZJYL $0.42
  • Average True Range (ATR)
  • NSPR 0.15
  • ZJYL 0.05
  • MACD
  • NSPR -0.03
  • ZJYL 0.00
  • Stochastic Oscillator
  • NSPR 29.05
  • ZJYL 24.17

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

Share on Social Networks: